Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Toujeo vs Tresiba in insulin-naive adults with type 2 diabetes mellitus
2015-005101-36Phase 4Completed
- Sponsor
- Sanofi
- Start
- Feb 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in type 2 diabetes mellitus (T2DM) comparing Toujeo with Tresiba (2 arms). Primary endpoint: Change from baseline in HbA1c (primary). Started Feb 2016; status: completed.
02
Drugs
insulin glargineinsulin degludec
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2015-005101-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-005101-36.